Cargando…

A pilot screening for cognitive impairment through voice technology (WAY2AGE)

Voice technology has grown exponentially, offering an opportunity to different fields, such as the health area. Considering that language can be a sign of cognitive impairment and most screening tools are based on speech measures, these devices are of interest. The aim of this work was to examine a...

Descripción completa

Detalles Bibliográficos
Autores principales: Moret-Tatay, Carmen, Iborra-Marmolejo, Isabel, Jorques-Infante, María José, Bernabé-Valero, Gloria, Beneyto-Arrojo, María José, Irigaray, Tatiana Quarti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204663/
https://www.ncbi.nlm.nih.gov/pubmed/37221628
http://dx.doi.org/10.1186/s40359-023-01212-4
_version_ 1785045879669915648
author Moret-Tatay, Carmen
Iborra-Marmolejo, Isabel
Jorques-Infante, María José
Bernabé-Valero, Gloria
Beneyto-Arrojo, María José
Irigaray, Tatiana Quarti
author_facet Moret-Tatay, Carmen
Iborra-Marmolejo, Isabel
Jorques-Infante, María José
Bernabé-Valero, Gloria
Beneyto-Arrojo, María José
Irigaray, Tatiana Quarti
author_sort Moret-Tatay, Carmen
collection PubMed
description Voice technology has grown exponentially, offering an opportunity to different fields, such as the health area. Considering that language can be a sign of cognitive impairment and most screening tools are based on speech measures, these devices are of interest. The aim of this work was to examine a screening tool for Mild Cognitive Impairment (MCI) through voice technology. For this reason, the WAY2AGE voice Bot was tested across Mini-Mental (MMSE) scores. The main results depict a strong relationship between MMSE and WAY2AGE scores, as well as a good AUC value to discriminate between no cognitive impairment (NCI) and MCI groups. However, a relationship between age and WAY2AGE scores, but not between age and MMSE scores, was found. This would indicate that, even if WAY2AGE seems sensitive to detect MCI, the voice tool is age-sensitive and not as robust as the traditional MMSE scale. Future lines of research should look more deeply into parameters that distinguish developmental changes. As a screening tool, these results are of interest for the health area and for at-risk older adults.
format Online
Article
Text
id pubmed-10204663
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102046632023-05-25 A pilot screening for cognitive impairment through voice technology (WAY2AGE) Moret-Tatay, Carmen Iborra-Marmolejo, Isabel Jorques-Infante, María José Bernabé-Valero, Gloria Beneyto-Arrojo, María José Irigaray, Tatiana Quarti BMC Psychol Research Voice technology has grown exponentially, offering an opportunity to different fields, such as the health area. Considering that language can be a sign of cognitive impairment and most screening tools are based on speech measures, these devices are of interest. The aim of this work was to examine a screening tool for Mild Cognitive Impairment (MCI) through voice technology. For this reason, the WAY2AGE voice Bot was tested across Mini-Mental (MMSE) scores. The main results depict a strong relationship between MMSE and WAY2AGE scores, as well as a good AUC value to discriminate between no cognitive impairment (NCI) and MCI groups. However, a relationship between age and WAY2AGE scores, but not between age and MMSE scores, was found. This would indicate that, even if WAY2AGE seems sensitive to detect MCI, the voice tool is age-sensitive and not as robust as the traditional MMSE scale. Future lines of research should look more deeply into parameters that distinguish developmental changes. As a screening tool, these results are of interest for the health area and for at-risk older adults. BioMed Central 2023-05-23 /pmc/articles/PMC10204663/ /pubmed/37221628 http://dx.doi.org/10.1186/s40359-023-01212-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Moret-Tatay, Carmen
Iborra-Marmolejo, Isabel
Jorques-Infante, María José
Bernabé-Valero, Gloria
Beneyto-Arrojo, María José
Irigaray, Tatiana Quarti
A pilot screening for cognitive impairment through voice technology (WAY2AGE)
title A pilot screening for cognitive impairment through voice technology (WAY2AGE)
title_full A pilot screening for cognitive impairment through voice technology (WAY2AGE)
title_fullStr A pilot screening for cognitive impairment through voice technology (WAY2AGE)
title_full_unstemmed A pilot screening for cognitive impairment through voice technology (WAY2AGE)
title_short A pilot screening for cognitive impairment through voice technology (WAY2AGE)
title_sort pilot screening for cognitive impairment through voice technology (way2age)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204663/
https://www.ncbi.nlm.nih.gov/pubmed/37221628
http://dx.doi.org/10.1186/s40359-023-01212-4
work_keys_str_mv AT morettataycarmen apilotscreeningforcognitiveimpairmentthroughvoicetechnologyway2age
AT iborramarmolejoisabel apilotscreeningforcognitiveimpairmentthroughvoicetechnologyway2age
AT jorquesinfantemariajose apilotscreeningforcognitiveimpairmentthroughvoicetechnologyway2age
AT bernabevalerogloria apilotscreeningforcognitiveimpairmentthroughvoicetechnologyway2age
AT beneytoarrojomariajose apilotscreeningforcognitiveimpairmentthroughvoicetechnologyway2age
AT irigaraytatianaquarti apilotscreeningforcognitiveimpairmentthroughvoicetechnologyway2age
AT morettataycarmen pilotscreeningforcognitiveimpairmentthroughvoicetechnologyway2age
AT iborramarmolejoisabel pilotscreeningforcognitiveimpairmentthroughvoicetechnologyway2age
AT jorquesinfantemariajose pilotscreeningforcognitiveimpairmentthroughvoicetechnologyway2age
AT bernabevalerogloria pilotscreeningforcognitiveimpairmentthroughvoicetechnologyway2age
AT beneytoarrojomariajose pilotscreeningforcognitiveimpairmentthroughvoicetechnologyway2age
AT irigaraytatianaquarti pilotscreeningforcognitiveimpairmentthroughvoicetechnologyway2age